Examkin

Question

Difficulty: MediumEndocrinology and Metabolism

A 45-year-old man is evaluated for resistant hypertension. His blood pressure is 168/102 mmHg despite adherence to maximum tolerated doses of amlodipine, lisinopril, and doxazosin. Laboratory evaluation reveals a serum potassium of 3.1 mEq/L. Arrange the following steps in the correct diagnostic and management sequence for evaluating and treating this patient's most likely condition.

  1. 1Measure the plasma aldosterone concentration to plasma renin activity ratio
  2. 2Perform a confirmatory intravenous saline infusion test
  3. 3Obtain a high-resolution CT scan of the adrenal glands
  4. 4Perform adrenal venous sampling
  5. 5Proceed with unilateral laparoscopic adrenalectomy

Answer

The correct diagnostic and therapeutic sequence is: 1) Measure the plasma aldosterone-to-renin ratio, 2) Perform a confirmatory test like a saline infusion, 3) Obtain a high-resolution adrenal CT scan, 4) Perform adrenal venous sampling, and 5) Proceed with unilateral adrenalectomy.
The evaluation of primary hyperaldosteronism strictly follows a phased approach to prevent misdiagnosis and avoid unnecessary surgery. It begins with screening (aldosterone-to-renin ratio) in high-risk patients, such as those with resistant hypertension and hypokalemia. Positive screens must be verified with confirmatory suppression testing (e.g., saline infusion or oral sodium loading) because screening tests can yield false positives. Only after definitive biochemical confirmation should localization be attempted with an adrenal CT scan. Because non-functioning adrenal incidentalomas are highly prevalent (especially in older adults), CT alone cannot reliably dictate surgery. Therefore, adrenal venous sampling is required to confirm unilateral hypersecretion (lateralization) before definitively treating the patient with a unilateral laparoscopic adrenalectomy.

Step-by-Step Solution

1
Identify the patient's risk for primary hyperaldosteronism and perform initial screening.
Measurement of the plasma aldosterone concentration to plasma renin activity ratio.
The patient has treatment-resistant hypertension and hypokalemia, making primary hyperaldosteronism highly likely. Biochemical screening is always the first step.
2
Confirm the diagnosis of primary hyperaldosteronism biochemically.
Intravenous saline infusion test.
An elevated screening ratio requires confirmation to prove that aldosterone secretion is autonomous and fails to suppress with a sodium load.
3
Localize the source of excess aldosterone production radiographically.
High-resolution CT scan of the adrenal glands.
Imaging is performed only after biochemical confirmation to exclude adrenocortical carcinoma and assist in planning venous sampling anatomy.
4
Differentiate between a unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia.
Adrenal venous sampling.
CT scans frequently reveal incidental non-functioning nodules. Adrenal venous sampling is the gold standard required to prove which gland is hypersecreting aldosterone before pursuing surgery.
5
Provide definitive treatment for confirmed unilateral disease.
Unilateral laparoscopic adrenalectomy.
Surgical removal of the hyperfunctioning gland cures or significantly improves hypertension and hypokalemia in patients with unilateral disease.

Key Concept

The diagnostic and management algorithm for primary hyperaldosteronism requires sequential biochemical screening, biochemical confirmation, radiologic localization, functional subtyping via venous sampling, and finally targeted surgical or medical therapy.
Rate this question

Topics

Endocrinology and Metabolism

More questions from this topic